Skip to main content
Top
Literature
1.
go back to reference Verbiest A, Pirenne J, Dierickx D (2014) De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Rev 28:269–279CrossRef Verbiest A, Pirenne J, Dierickx D (2014) De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Rev 28:269–279CrossRef
2.
go back to reference Padmanabhan A, Conelly-Smith L, Aqui N et al (2019) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from writing committee of the American society for apheresis: the English special issue. J Clin Apher 34:171–354CrossRef Padmanabhan A, Conelly-Smith L, Aqui N et al (2019) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from writing committee of the American society for apheresis: the English special issue. J Clin Apher 34:171–354CrossRef
3.
go back to reference Turner D, Schreiber R, Grant D, Hebert D, Sherman PM et al (2006) Hemolytic uremic syndrome after pediatric liver transplantation. J Pediatr Gastroenterol Nutr 43(1):109–112CrossRef Turner D, Schreiber R, Grant D, Hebert D, Sherman PM et al (2006) Hemolytic uremic syndrome after pediatric liver transplantation. J Pediatr Gastroenterol Nutr 43(1):109–112CrossRef
4.
go back to reference Furmanczyk A, Komuda-Leszek E, Durlik M et al (2009) Atypical calcineurine inhibitor-induced hemolytic uremic syndrome after liver transplantation. Ann Transplant 14(4):47–51PubMed Furmanczyk A, Komuda-Leszek E, Durlik M et al (2009) Atypical calcineurine inhibitor-induced hemolytic uremic syndrome after liver transplantation. Ann Transplant 14(4):47–51PubMed
5.
go back to reference Belousova T, Tong YT, Conyers J, Klein K, Bai Y, Tint H, Castilo B et al (2018) Successful use of plasmapheresis for hyperbilirubinemia in a premature newborn on extracorporeal membrane oxygenation. Am J Clin Pathol 149:S157–S161CrossRef Belousova T, Tong YT, Conyers J, Klein K, Bai Y, Tint H, Castilo B et al (2018) Successful use of plasmapheresis for hyperbilirubinemia in a premature newborn on extracorporeal membrane oxygenation. Am J Clin Pathol 149:S157–S161CrossRef
6.
go back to reference Nishi H, Hanafusa N, Kondo Y, Nangaku M, SuguwaraY MM, Noiri E, Fujita T et al (2006) Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy. Clin J Am Soc Nephrol 1:811–819CrossRef Nishi H, Hanafusa N, Kondo Y, Nangaku M, SuguwaraY MM, Noiri E, Fujita T et al (2006) Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy. Clin J Am Soc Nephrol 1:811–819CrossRef
Metadata
Title
Therapeutic Plasma Exchange (TPE) for Liver Transplant Associated-Thrombotic Microangiopathy (TA-TMA) in a 5 Month Old Infant
Authors
Prashant Pandey
Shweta Ranjan
Abhideep Chaudhary
Divya Setya
Praveen Kumar
Publication date
01-10-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01269-w

Other articles of this Issue 4/2020

Indian Journal of Hematology and Blood Transfusion 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine